Research Papers

25 of 1016 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic …
Semba R; Uchida K; Hirokawa Y; Shiraishi T; Onishi T; Sasaki T; Inoue T; Watanabe M.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Perioperative care based on roy adaptation model in elderly patients with benign prostatic hyperplasia: impact on psych…
Peng YN; Jin L; Peng EJ; Zhang L.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Distinct effects of Fgf7 and Fgf10 on the terminal differentiation of murine bladder urothelium revealed using an organ…
Suda K; Matsumoto Y; Ochi T; Koga H; Hattori N; Yamataka A; Nakamura T.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Efficacy and safety of minimally invasive percutaneous nephrolithotomy versus retrograde intrarenal surgery in the trea…
Liu Y; Zhang H; Wen Z; Jiang Y; Huang J; Wang C; Chen C; Wang J; Bao E; Yang X.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progr…
Zou Z; Li Z; Sun W; Gao W; Liu B; Liu J; Guo Y.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Longitudinal trend of urolithiasis incidence rates among world countries during past decades.
Borumandnia N; Fattahi P; Talebi A; Taheri M; Alvani MS; Balani MM; Ashrafi S; Alavimajd H.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effects of heart failure and coronary artery disease on erectile dysfunction: a two-sample mendelian randomization stud…
Shao K; Chen W; Li Y; Zheng H; Hu R; Zhang J; Sun T.
BMC Urol (Unknown)
Published: 2023
2/6 Transparent
Robotic ureteral reconstruction for benign ureteral strictures: a systematic review of surgical techniques, complicatio…
Yang K; Pang KH; Fan S; Li X; Osman NI; Chapple CR; Zhou L; Li X.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
An innovative method for occluding the urethral meatus and accessing urethra strictures in retrograde urethrography in …
Li W; Man L; Huang G.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery.
Aizawa T; Maebayashi T; Ishibashi N; Sakaguchi M; Sato A; Yamaguchi K.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network …
Su YT; Chen HL; Teoh JY; Chan VW; Wu WJ; Lee HY.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Patient's safety and satisfaction on same day discharge after robotic and laparoscopic radical prostatectomy versus dis…
Faria EF; Machado RD; Gualberto RJC; Milani MAV; Bidinotto LT; Machado MT; Dos Reis R; Bidinotto DNPB.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Complications after partial nephrectomy: robotics overcomes open surgery and laparoscopy: the PMSI French national data…
Bic A; Mazeaud C; Salleron J; Bannay A; Balkau B; Larose C; Hubert J; Eschwège P.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis pre…
Tai R; Leng J; Li W; Wu Y; Yang J.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic…
Wang X; Liu H; Tang G; Wu G; Chu Y; Wu J; Cui Y.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Serum and 24-hour urinary tests cost-effectiveness in stone formers.
Mohammadi A; Farabi H; Baghdadabad LZ; Narouie B; Reis LO; Aghamir SMK.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Robot-assisted laparoscopic pyeloplasty is a valid option for ureteropelvic junction obstruction repair in adults with …
Razavi S; Babbin J; Dahl D.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Improved outcome in penile cancer with radiologically enhanced stratification protocol for lymph node staging procedure…
Kumar V; Kumar PR; Juette A; Pawaroo D; Ball RY; Sethia KK.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
An uncommon mimicker of renal malignancy: IgG4-related disease.
Thia I.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through int…
Cheng H; Liu Y; Chen G.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Urachal xanthogranuloma: a rare but important case presenting as a urachal mass.
Jain K; Jain E; DiLena R; Saleeb R; Jain U.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Surgical resection of retinoblastoma-associated bladder leiomyosarcoma during pregnancy: a case report.
Hoshina H; Taguchi S; Suyama H; Kishitani K; Akiyama Y; Yamada Y; Sato Y; Yamada D; Akiba N; Kumasawa K; Mori-Uchino M; Osuga Y; Kume H.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma.
Zhu S; Li H; Fan Y; Tang C.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared